One step closer to the treatment of male infertility

One step closer to the treatment of male infertility

Dr Michail Nomikos is a biomedical researcher at the School of Medicine Institute of Molecular & Experimental Medicine and has received the prestigious 2013 Investigator Achievement Award at the annual meeting of the American Society for Reproductive Medicine (ASRM)

The Greek researcher of Demokritos National Center for Scientific Research was selected by the Editorial Board of Fertility and Sterility magazine, as the lead author of Phospholipase Cζ rescues failed oocyte activation in a prototype of male factor infertility article. His related honoured work is the result of the cooperation of the Medical School of Cardiff University, UK, and Demokritos National Center for Scientific Research, GR, and suggests a revolutionary model for the treatment of male infertility caused by infertility-linked sperm phospholipase Cζ mutations. According to Dr. Nomikos, phospholipase Cζ microinjections into human ova induce Ca2+ oscillations and trigger embryogenesis.

Planning for official clinical trials is currently underway in Britain and Greece. Fertility and Sterility Investigator Award was first established by the American Society of Reproductive Medicine honouring the contribution of young scientists in the field of Reproductive Medicine.

Dr. Michail Nomikos received his PhD in Biochemistry Molecular Biology in 2006 and has been a Postdoctoral Fellow at the Institute of Nuclear & Radiological Sciences & Technology, Energy & Safety (I.N.RA.S.T.E.S.) of Demokritos National Center for Scientific Research.

Demokritos’s researchers George Nounesis and Maria Theodoridou of the Biomolecular Physics Laboratory and Evaggelia Livaniou, Christos Zikos and Vyronia Vasilakopoulou of the Immunochemistry Laboratory also contributed to the awarded publication. Anthony Lai, Professor in the Medical School of Cardiff University, is the Scientific Supervisor of the research.